{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:12:36Z","timestamp":1793729556831,"version":"4.6.1"},"reference-count":61,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","doi-asserted-by":"publisher","award":["FI19\/00001"],"award-info":[{"award-number":["FI19\/00001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","doi-asserted-by":"publisher","award":["FIS 18\/00075"],"award-info":[{"award-number":["FIS 18\/00075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","doi-asserted-by":"publisher","award":["CIBERES 2021"],"award-info":[{"award-number":["CIBERES 2021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","doi-asserted-by":"publisher","award":["SEPAR 2018"],"award-info":[{"award-number":["SEPAR 2018"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","doi-asserted-by":"publisher","award":["PID2020-112526RB-I00"],"award-info":[{"award-number":["PID2020-112526RB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["FI19\/00001"],"award-info":[{"award-number":["FI19\/00001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["FIS 18\/00075"],"award-info":[{"award-number":["FIS 18\/00075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["CIBERES 2021"],"award-info":[{"award-number":["CIBERES 2021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["SEPAR 2018"],"award-info":[{"award-number":["SEPAR 2018"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2020-112526RB-I00"],"award-info":[{"award-number":["PID2020-112526RB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Spanish Respiratory Society (SEPAR)","doi-asserted-by":"publisher","award":["FI19\/00001"],"award-info":[{"award-number":["FI19\/00001"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Spanish Respiratory Society (SEPAR)","doi-asserted-by":"publisher","award":["FIS 18\/00075"],"award-info":[{"award-number":["FIS 18\/00075"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Spanish Respiratory Society (SEPAR)","doi-asserted-by":"publisher","award":["CIBERES 2021"],"award-info":[{"award-number":["CIBERES 2021"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Spanish Respiratory Society (SEPAR)","doi-asserted-by":"publisher","award":["SEPAR 2018"],"award-info":[{"award-number":["SEPAR 2018"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Spanish Respiratory Society (SEPAR)","doi-asserted-by":"publisher","award":["PID2020-112526RB-I00"],"award-info":[{"award-number":["PID2020-112526RB-I00"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Science and Innovation","award":["FI19\/00001"],"award-info":[{"award-number":["FI19\/00001"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["FIS 18\/00075"],"award-info":[{"award-number":["FIS 18\/00075"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["CIBERES 2021"],"award-info":[{"award-number":["CIBERES 2021"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["SEPAR 2018"],"award-info":[{"award-number":["SEPAR 2018"]}]},{"name":"Spanish Ministry of Science and Innovation","award":["PID2020-112526RB-I00"],"award-info":[{"award-number":["PID2020-112526RB-I00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Overactivation of poly (ADPribose) polymerases (PARPs) is involved in cancer-induced cachexia. We hypothesized that the PARP inhibitor rucaparib may improve muscle mass and reduce damage in cancer cachexia mice. In mouse diaphragm and gastrocnemius (LP07 lung adenocarcinoma) treated with PARP inhibitor (rucaparib,150 mg\/kg body weight\/24 h for 20 days) and in non-tumor control animals, body, muscle, and tumor weights; tumor area; limb muscle strength; physical activity; muscle structural abnormalities, damage, and phenotype; PARP activity; and proteolytic and autophagy markers were quantified. In cancer cachexia mice compared to non-cachexia controls, body weight and body weight gain, muscle weight, limb strength, physical activity, and muscle fiber size significantly declined, while levels of PARP activity, plasma troponin I, muscle damage, and proteolytic and autophagy markers increased. Treatment with the PARP inhibitor rucaparib elicited a significant improvement in body weight gain, tumor size and weight, physical activity, muscle damage, troponin I, and proteolytic and autophagy levels. PARP pharmacological inhibition did not exert any significant improvements in muscle weight, fiber size, or limb muscle strength. Treatment with rucaparib, however, improved muscle damage and structural abnormalities and physical activity in cancer cachexia mice. These findings suggest that rucaparib exerts its beneficial effects on cancer cachexia performance through the restoration of muscle structure.<\/jats:p>","DOI":"10.3390\/cancers14122894","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T09:26:48Z","timestamp":1655026008000},"page":"2894","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Attenuation of Muscle Damage, Structural Abnormalities, and Physical Activity in Respiratory and Limb Muscles following Treatment with Rucaparib in Lung Cancer Cachexia Mice"],"prefix":"10.3390","volume":"14","author":[{"given":"Maria","family":"P\u00e9rez-Peir\u00f3","sequence":"first","affiliation":[{"name":"Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, Department of Medicine and Life Sciences (MELIS), Hospital del Mar, Medical Research Institute (IMIM), Parc de Salut Mar, Universitat Pompeu Fabra (UPF), Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Duran","sequence":"additional","affiliation":[{"name":"Scientific, Statistics and Technical Department, Hospital del Mar, Medical Research Institute (IMIM), Parc de Salut Mar, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-1496","authenticated-orcid":false,"given":"Jos\u00e9","family":"Y\u00e9lamos","sequence":"additional","affiliation":[{"name":"Cancer Research Program, Hospital del Mar, Medical Research Institute (IMIM), 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Barreiro","sequence":"additional","affiliation":[{"name":"Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, Department of Medicine and Life Sciences (MELIS), Hospital del Mar, Medical Research Institute (IMIM), Parc de Salut Mar, Universitat Pompeu Fabra (UPF), Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.biocel.2004.10.003","article-title":"Molecular mechanisms involved in muscle wasting in cancer and ageing: Cachexia versus sarcopenia","volume":"37","author":"Busquets","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: New insights into an old problem","volume":"42","author":"Muscaritoli","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bossi, P., Delrio, P., Mascheroni, A., and Zanetti, M. (2021). The Spectrum of Malnutrition\/Cachexia\/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13061980"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PPO.0000000000000100","article-title":"Cancer cachexia, recent advances, and future directions","volume":"21","author":"Penet","year":"2015","journal-title":"Cancer J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Penedo-V\u00e1zquez, A., Duran, X., Mateu, J., L\u00f3pez-Postigo, A., and Barreiro, E. (2021). Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia. Molecules, 26.","DOI":"10.3390\/molecules26164904"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ma\u00f1as-Garc\u00eda, L., Penedo-V\u00e1zquez, A., L\u00f3pez-Postigo, A., Deschrevel, J., Dur\u00e1n, X., and Barreiro, E. (2020). Prolonged Immobilization Exacerbates the Loss of Muscle Mass and Function Induced by Cancer-Associated Cachexia through Enhanced Proteolysis in Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218167"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcp.28992","article-title":"Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats","volume":"235","author":"Busquets","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Naito, T., Okayama, T., Aoyama, T., Ohashi, T., Masuda, Y., Kimura, M., Shiozaki, H., Murakami, H., Kenmotsu, H., and Taira, T. (2017). Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3795-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/apjon.apjon_68_18","article-title":"Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia","volume":"6","author":"Naito","year":"2019","journal-title":"Asia-Pac. J. Oncol. Nurs."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Thoresen","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Santos","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e4109","DOI":"10.7717\/peerj.4109","article-title":"Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats","volume":"5","author":"Busquets","year":"2017","journal-title":"PeerJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/jcp.25851","article-title":"Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype","volume":"232","author":"Langohr","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/jcp.24611","article-title":"Pharmacological strategies in lung cancer-induced cachexia: Effects on muscle proteolysis, autophagy, structure, and weakness","volume":"229","author":"Fermoselle","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/expphysiol.2013.072496","article-title":"Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice","volume":"98","author":"Fermoselle","year":"2013","journal-title":"Exp. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/ars.2009.2818","article-title":"Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats","volume":"12","author":"Fontes","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.febslet.2005.02.017","article-title":"Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats","volume":"579","author":"Barreiro","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jcsm.12678","article-title":"Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: Lessons from human and animal studies","volume":"12","author":"Martin","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2014.11.006","article-title":"Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer","volume":"79","author":"Rodriguez","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"L\u00fcscher, B., Ahel, I., Altmeyer, M., Ashworth, A., Bai, P., Chang, P., Cohen, M., Corda, D., Dantzer, F., and Daugherty, M.D. (2021). ADP-ribosyltransferases, an update on function and nomenclature. FEBS J.","DOI":"10.1111\/febs.16142"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): Novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17860","DOI":"10.1074\/jbc.274.25.17860","article-title":"PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase","volume":"274","author":"Rolli","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuint.2013.01.020","article-title":"Expression and activity of PARP family members in the hippocampus during systemic inflammation: Their role in the regulation of prooxidative genes","volume":"62","author":"Czapski","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.molcel.2015.01.034","article-title":"Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance","volume":"58","author":"Bai","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.bbagen.2015.09.020","article-title":"MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-\/-) and Parp-2(-\/-) mice with lung cancer cachexia","volume":"1850","author":"Fermoselle","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3389\/fcell.2021.801200","article-title":"Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics","volume":"9","author":"Richard","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0076-6879(05)09029-4","article-title":"Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair","volume":"409","author":"Dantzer","year":"2006","journal-title":"Methods Enzymol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood.2021012805","article-title":"Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice","volume":"139","author":"Lutfi","year":"2022","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1101\/gad.334425.119","article-title":"The impact of PARPs and ADP-ribosylation on inflammation and host\u2013pathogen interactions","volume":"34","author":"Fehr","year":"2020","journal-title":"Genes Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1101\/gad.334284.119","article-title":"The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism","volume":"34","author":"Bai","year":"2020","journal-title":"Genes Dev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00134-004-2301-x","article-title":"Role of PARP on iNOS pathway during endotoxin-induced acute lung injury","volume":"30","author":"Kiefmann","year":"2004","journal-title":"Intensive Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.anes.0000299434.86640.15","article-title":"Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury","volume":"108","author":"Vaschetto","year":"2008","journal-title":"Anesthesiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"F387","DOI":"10.1152\/ajprenal.00436.2003","article-title":"Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury","volume":"288","author":"Zheng","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","article-title":"Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors","volume":"25","author":"Pacher","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jse.2016.11.009","article-title":"Neer Award 2016: Reduced muscle degeneration and decreased fatty infiltration after rotator cuff tear in a poly(ADP-ribose) polymerase 1 (PARP-1) knock-out mouse model","volume":"26","author":"Kuenzler","year":"2017","journal-title":"J. Shoulder Elb. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bph.13735","article-title":"The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury","volume":"175","author":"Ahmad","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/pgs-2019-0113","article-title":"PARP inhibitors: A tsunami of indications in different malignancies","volume":"21","author":"Haddad","year":"2020","journal-title":"Pharmacogenomics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40164-019-0154-9","article-title":"Advances and perspectives of PARP inhibitors","volume":"8","author":"Yi","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/jcmm.14133","article-title":"PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms","volume":"23","author":"Jiang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_45","first-page":"2","article-title":"PARP Inhibitors in Advanced Ovarian Cancer: A Review of Long-term Efficacy and Survival Rates","volume":"9","author":"Scott","year":"2021","journal-title":"Eur. Med. J. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Valabrega, G., Scotto, G., Tuninetti, V., Pani, A., and Scaglione, F. (2021). Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084203"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1200\/EDBK_288015","article-title":"PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair","volume":"40","author":"Konstantinopoulos","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.20226","article-title":"Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs","volume":"110","author":"Peluffo","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_49","first-page":"639","article-title":"New murine cell line derived from a spontaneous lung tumor induces paraneoplastic syndromes","volume":"18","author":"Urtreger","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18041","DOI":"10.1002\/jcp.28437","article-title":"Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice","volume":"234","author":"Tang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3892\/ijmm.2015.2286","article-title":"Loquat leaf extract enhances myogenic differentiation, improves muscle function and attenuates muscle loss in aged rats","volume":"36","author":"Sung","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-61779-270-0_8","article-title":"Detecting and quantifying pADPr in vivo","volume":"780","author":"Lai","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/CS20140428","article-title":"Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD","volume":"128","author":"Ausin","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12967-016-1003-9","article-title":"Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: Influence of underlying emphysema","volume":"14","author":"Blanco","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcp.25600","article-title":"Inflammatory Events and Oxidant Production in the Diaphragm, Gastrocnemius, and Blood of Rats Exposed to Chronic Intermittent Hypoxia: Therapeutic Strategies","volume":"232","author":"Gea","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.surg.2009.12.006","article-title":"Post Ischemic PARP Inhibition Reduces Ischemia Reperfusion Injury in a Hind-Limb Ischemia Model","volume":"148","author":"Crawford","year":"2010","journal-title":"Surgery"},{"key":"ref_58","first-page":"F428","article-title":"Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells","volume":"277","author":"Filipovic","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.18632\/aging.100696","article-title":"Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism","volume":"6","author":"Mohamed","year":"2014","journal-title":"Aging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Jank\u00f3, L., S\u00e1ri, Z., Kov\u00e1cs, T., Kis, G., Sz\u00e1nt\u00f3, M., Antal, M., Juh\u00e1sz, G., and Bai, P. (2020). Silencing of PARP2 Blocks Autophagic Degradation. Cells, 9.","DOI":"10.3390\/cells9020380"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/12\/2894\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:28:17Z","timestamp":1760138897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/12\/2894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["cancers14122894"],"URL":"https:\/\/doi.org\/10.3390\/cancers14122894","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]}}}